SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Grygiel Nancy A. – ‘3’ for 6/24/20 re: Amgen Inc.

On:  Wednesday, 7/1/20, at 8:00pm ET   ·   For:  6/24/20   ·   Accession #:  1127602-20-20691   ·   File #:  1-37702

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/01/20  Grygiel Nancy A.                  3                      2:10K  Amgen Inc.                        Restricted Stock Sy… Inc

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Initial Statement of Beneficial Ownership of        HTML      3K 
                Securities by an Insider -- form3.xml/2.6                        
 2: EX-24       Power of Attorney (Public): Power of Attorney          1      5K

‘3’   —   Initial Statement of Beneficial Ownership of Securities by an Insider — form3.xml/2.6



        

This ‘3’ Document is an XML Data File that may be rendered in various formats:

  Form 3    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
XML Data rendering:  Initial Statement of Beneficial Ownership of Securities by an Insider
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<ownershipDocument>
<schemaVersion> X0206 </schemaVersion>
<documentType> 3 </documentType>
<periodOfReport> 2020-06-24 </periodOfReport>
<noSecuritiesOwned> 0 </noSecuritiesOwned>
<issuer>
<issuerCik> 0000318154 </issuerCik>
<issuerName> AMGEN INC </issuerName>
<issuerTradingSymbol> AMGN </issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik> 0001816414 </rptOwnerCik>
<rptOwnerName> Grygiel Nancy A. </rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1> ONE AMGEN CENTER DRIVE </rptOwnerStreet1>
<rptOwnerStreet2></rptOwnerStreet2>
<rptOwnerCity> THOUSAND OAKS </rptOwnerCity>
<rptOwnerState> CA </rptOwnerState>
<rptOwnerZipCode> 91320 </rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isOfficer> 1 </isOfficer>
<officerTitle> SVP & CCO </officerTitle>
</reportingOwnerRelationship>
</reportingOwner>
<nonDerivativeTable>
<nonDerivativeHolding>
<securityTitle>
<value> Common Stock </value>
</securityTitle>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 3142 </value>
<footnoteId id="F1"/>
<footnoteId id="F2"/>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeHolding>
<nonDerivativeHolding>
<securityTitle>
<value> Common Stock </value>
</securityTitle>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 88.786 </value>
<footnoteId id="F3"/>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> I </value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value> 401(k) Plan </value>
</natureOfOwnership>
</ownershipNature>
</nonDerivativeHolding>
</nonDerivativeTable>
<derivativeTable>
<derivativeHolding>
<securityTitle>
<value> Nqso (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 162.60 </value>
</conversionOrExercisePrice>
<exerciseDate>
<value> 2019-05-01 </value>
<footnoteId id="F4"/>
</exerciseDate>
<expirationDate>
<value> 2027-05-01 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 4139 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeHolding>
<derivativeHolding>
<securityTitle>
<value> Nqso (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 177.46 </value>
</conversionOrExercisePrice>
<exerciseDate>
<value> 2020-04-27 </value>
<footnoteId id="F5"/>
</exerciseDate>
<expirationDate>
<value> 2028-04-27 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 3470 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeHolding>
<derivativeHolding>
<securityTitle>
<value> Nqso (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 177.31 </value>
</conversionOrExercisePrice>
<exerciseDate>
<value> 2021-05-03 </value>
<footnoteId id="F6"/>
</exerciseDate>
<expirationDate>
<value> 2029-05-03 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 3948 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeHolding>
<derivativeHolding>
<securityTitle>
<value> Nqso (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 236.36 </value>
</conversionOrExercisePrice>
<exerciseDate>
<value> 2022-05-05 </value>
<footnoteId id="F7"/>
</exerciseDate>
<expirationDate>
<value> 2030-05-05 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 3542 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeHolding>
</derivativeTable>
<footnotes>
<footnote id="F1"> These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 748 RSUs which fully vest on 8/1/2020; 159 RSUs which fully vest on 5/1/2021; 302 RSUs which vest in two installments of 149 on 4/27/2021 and 153 on 4/27/2022; 452 RSUs which vest in two installments of 149 on 5/3/2021 and 5/3/2022 and one installment of 154 on 5/3/2023; and 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. </footnote>
<footnote id="F2"> These shares include 142 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. </footnote>
<footnote id="F3"> These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. </footnote>
<footnote id="F4"> 2,731 of these non-qualified stock options have vested and are exercisable and 1,408 of these options will vest and become exercisable on 5/1/2021. </footnote>
<footnote id="F5"> 1,145 of these non-qualified stock options have vested and are exercisable and the remaining options will vest and become exercisable in installments of 1,145 on 4/27/2021 and 1,180 on 4/27/2022. </footnote>
<footnote id="F6"> These non-qualified stock options will vest and become exercisable in three installments of 1,302 on 5/3/2021, 1,303 on 5/3/2022 and 1,343 on 5/3/2023. </footnote>
<footnote id="F7"> These non-qualified stock options will vest and become exercisable in three installments of 1,168 on 5/5/2022, 1,169 on 5/5/2023 and 1,205 on 5/5/2024. </footnote>
</footnotes>
<ownerSignature>
<signatureName> /s/ Andrea A. Robinson, Attorney-in-Fact for Ms. Grygiel </signatureName>
<signatureDate> 2020-06-30 </signatureDate>
</ownerSignature>
</ownershipDocument>


↑Top
Filing Submission 0001127602-20-020691   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., May 4, 4:37:47.1pm ET